8-2086 (1st Cir. Feb. 13, 2020) (Kayatta, J). [Continue Reading] Life Sciences Intellectual Property Review: "Gilead to face HIV antitrust claims," Rory O'Neill, March 05, 2020, 11:30 AM Drugmakers including Gilead Sciences must face antitrust claims related to HIV drugs, after the US District Court for th